| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:IV-23
CAS:2326007-49-0
Package:50mg/RMB 13800;100mg/RMB 17500;25mg/RMB 10600
|
IV-23 manufacturers
- IV-23
-
- $1980.00 / 50mg
-
2025-10-27
- CAS:2326007-49-0
- Min. Order:
- Purity:
- Supply Ability: 10g
- IV-23
-
- $1980.00 / 50mg
-
2025-07-17
- CAS:2326007-49-0
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| Product Name: | IV-23 | | Synonyms: | IV-23;Methanone, (5-bromo-2,3-dihydro-1H-indol-1-yl)(3,4,5-trimethoxyphenyl)-;IV23,IV 23 | | CAS: | 2326007-49-0 | | MF: | C18H18BrNO4 | | MW: | 392.24 | | EINECS: | | | Product Categories: | | | Mol File: | 2326007-49-0.mol |  |
| | IV-23 Chemical Properties |
| Boiling point | 543.3±50.0 °C(Predicted) | | density | 1.427±0.06 g/cm3(Predicted) | | pka | -1.85±0.20(Predicted) |
| | IV-23 Usage And Synthesis |
| Uses | IV-23 (Compound 20) is a potent Noxa mediated apoptosis inducer, and it is a promising anticancer agent with potential. IV-23 inhibits cell growths in vitro and in vivo, reduces colony formation, arrests cell cycle at M phase, and induces esophageal squamous cell carcinoma (ESCC)[1]. | | References | [1] Fu DJ, et al. Discovery of indoline derivatives that inhibit esophageal squamous cell carcinoma growth by Noxa mediated apoptosis. Bioorg Chem. 2019 Aug 10;92:103190. DOI:10.1016/j.bioorg.2019.103190 |
| | IV-23 Preparation Products And Raw materials |
|